Providing HIV consultation, education and mentoring to healthcare professionals
The AETC Capitol Region Telehealth "Power Podcast" series allows you to listen to experts in the field from your computer or mobile device. Designed for the busy professional, you can learn about cultural competence in the treatment of HIV/AIDS from your office or "On-The-Go."
Drug-Drug Interactions with Antiretrovirals in Patients who are HIV Positive and Co-Infected with TB and HCV, Part 2 - HCV Focus: VIDEO Podcast
Click here to view the slides
Biographic Information for Keith Crawford, RPH, PhD
He has previously worked as a research associate in the Division of Clinical Pharmacology at the Johns Hopkins School of Medicine in Baltimore, MD., where he was engaged in HIV clinical research through the AIDS Clinical Trials Group (ACTG), the largest federally-funded system supporting HIV research in the world.
Dr. Crawford received a BS in biology from Cornell University and a BS in Pharmacy from Temple University. He completed a residency in Clinical Pharmacy at the National Institutes of Health (NIH) Clinical Center. He then earned a Ph.D. degree in pharmacology from the Uniformed Services University of the Health Sciences in Bethesda MD. He completed a post-doctoral fellowship in microbial genetics and biochemistry in the Laboratory of Biochemical Pharmacology in the Natl. Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) of the NIH.
Dr. Crawford has published research in leading journals such as Cancer Research, AIDS, Journal of The Acquired Immunodeficiency Syndrome (JAIDS), Lancet infectious Diseases and AIDS Research and Human Retroviruses He reviews submitted manuscripts for the journals AIDS and JAIDS. He also has many years experience as a clinical pharmacist specializing in pharmacotherapy of infectious diseases. Working with infectious disease physicians and other clinicians, he uses his expertise to assist in initiating and monitoring antiretroviral therapy, interpretation of HIV drug resistance tests and designing salvage regimens, minimizing risks of drug-drug interactions and drug side-effects and maximizing patient adherence.
He has served as the Clinical Director of the National Minority AIDS Education and Training Center (NMAETC) and the Pennsylvania Mid-Atlantic AIDS Education and Training Center at Howard University. He serves as a consultant for the Department of Health HIV/AIDS Administration in the District of Columbia and Prince Georges County, Maryland. He is also a consultant with the National Association of Addiction Professionals (NADAAC) and has developed training modules on the pharmacotherapy of substance abuse.